Gilead Sciences : Truvada Approved in China for Preventative HIV Use

By Matt Grossman

Gilead Sciences Inc.'s Truvada drug has been approved by the China National Medical Products Administration for pre-exposure prophylaxis against sexually acquired HIV-1, Gilead said Tuesday.

Truvada is the first medication approved for HIV prevention in China, Gilead said. It had already been approved for that use in the United States. In China, Truvada was previously approved as a treatment for HIV-1 infection in combination with other antriretroviral medications.

Between January and October 2019, 131,000 new HIV infections were reported in China, with sexual transmission the primary mode of infection, Gilead said, citing data from the China National Health Commission.

Write to Matt Grossman at [e-mail]